guest ::
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study
; ; ; ; ; ; ; ; ; ; ;
In
Leukemia : normal and malignant hemopoiesis 38(1), Seiten/Artikel-Nr.:126-135
2024 & 2023
Published: 25 November 2023
Online
DOI: 10.1038/s41375-023-02080-y
DOI: 10.18154/RWTH-CONV-252649
URL: https://publications.rwth-aachen.de/record/982586/files/982586.pdf
Einrichtungen
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online, print
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85178256217
WOS Core Collection: WOS:001109383900001
PubMed: pmid:38007586
Interne Identnummern
RWTH-CONV-252649
Datensatz-ID: 982586
Beteiligte Länder
Germany, Italy, Norway, Peoples R China, Spain, UK, USA
; 
; 
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF